Thanks Lopez, will read it properly later. There will be a lot...

  1. 553 Posts.
    Thanks Lopez, will read it properly later. There will be a lot of options with NSCLC in years to come I think. SPL seems to be very effective in moderating toxicity of established anti-cancer drugs. BLT were working on reversing chemo-resistance a year or two back. I'm sure there would be a lot of others working in the same space.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.